Table 3.
The different treatment options in CRC.
| Therapeutic method | Effects | Reference |
|---|---|---|
| Surgery | The cornerstone of CRC treatment | [120] |
| Chemotherapy | Prolongs survival and improves symptoms and quality of life | [121] |
| Radiotherapy | Achieves local control and improves long-term prognosis | [122] |
| Targeted therapy | Reduces potential liver metastasis associated with CRC (antiviral therapy) | [123] |
| Immunotherapy | Achieves long-term durable remission in patients | [124, 125] |
| Probiotics | Enhance the immune barrier, regulate the intestinal immune state, inhibit pathogenic enzyme activity, regulate CRC cell proliferation and apoptosis, regulate redox homeostasis, and reprogram intestinal microbial composition | [126] |
| Prebiotics | Stimulate the growth and/or activity of specific bacteria in the gut, improve host health, possess prebiotic potential, modulate gut microbiota composition, a product of fermentation metabolites, antiadhesive properties against pathogens, and alter the gene expression profile | [127] |
| Postbiotics | Modulate the composition of the gut microbiota and the functionality of the immune system, promote the CRC treatment effectiveness, and reduces its side effects in CRC patients | [128] |
| Antibiotics | Improve the treatment efficacy of oxaliplatin-based therapy and reduce cancer severity through controlling F. nucleatum | [129, 130] |
| Nonsteroidal anti-inflammatory drugs (NSAIDs) | Prolong survival time | [131] |
|
| ||
| Fecal microbiota transplantation (FMT) | Restores the sensitivity of patients to anticancer drugs and enhances the immune response | [132] |